chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Starting April I began feeling fatigued, forgetting things similar to brain fog, and sleeping for more than 10 hours and up to 18 hours. By May I was on Zoloft to bring my Seratonin up to try to prevent my fatigue. By June my blood pressure was dropping to dangerous low levels (68/43), I am lightheaded, dizzy, extremities going numb and tingling and almost passing out.  In June I was referred to a cardiologist. Since being referred I?ve had a heart monitor to wear, EKG, Echocardiogram, Tilt table test, nuclear stress test, and pet stress test. I have been diagnosed with Orthostatic hypotension.   Prior to the vaccine I have never had brain fog or severe problems with my heart or blood pressure being low to dangerous levels. This has severely affected my job and my daily personal life. I was an active person and now I?m doing good if I can  even function at work without passing out or take a shower without passing out.
After receiving the Shingrix vaccine (1st dose), I experienced pain and soreness in the shot location.  I know this is normal, but the pain has become deeper within the muscle and more severe.  It has been about 5 weeks since my Shingrix shot and I thought the pain would have subsided by now.  The pain is experienced when raising the arm or when touching the location.
Patient received 1st dose of the vaccine and tested positive for covid 5 days later; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (Patient received 1st dose of the vaccine and tested positive for covid 5 days later) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Apr-2021, the patient experienced COVID-19 (Patient received 1st dose of the vaccine and tested positive for covid 5 days later). At the time of the report, COVID-19 (Patient received 1st dose of the vaccine and tested positive for covid 5 days later) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Within 15-minutes of vaccination, the patient reported dizziness and a headache after receiving the second dose of the Pfizer vaccine. EMS evaluated the patient on-site. The patient was hypertensive (150/88) with an FSBG of 188mg/dl. EKG demonstrated pacer rhythm, no ectopy. The patient refused EMS transport. The patient then proceeded to Hospital Emergency Department. In the ED, the patient reported feeling lightheaded, a headache, and nausea without vomiting. During the ED visit, the patient reported mild improvement, but stated that she noticed some lightheadedness when standing. The physician administered 1L IV saline bolus, 4mg Zofran IV, and 1G of Acetaminophen PO. Tests were relatively unremarkable. The patient had improved and was discharged with diagnoses of Medication reaction (Pfizer COVID vaccine), HA, Dizziness, and Orthostasis without hypotension.
sore arm, around injection site, red and firm circular area. increased from date of vaccine to today. itchy.  tender.  no treatment except over the counter tylenol and motrin.
knocked out for 24-hours; did a lot of sleeping; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (knocked out for 24-hours) and SOMNOLENCE (did a lot of sleeping) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (knocked out for 24-hours) and SOMNOLENCE (did a lot of sleeping). At the time of the report, FEELING ABNORMAL (knocked out for 24-hours) and SOMNOLENCE (did a lot of sleeping) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported. No treatment information was reported.    This case was linked to MOD-2021-374831, MOD-2021-374841 (Patient Link).
This case was reported by a nurse via call center representative and described the occurrence of eye swelling in a 25-year-old female patient who received TWINRIX Adult (batch number 7C4Z3, expiry date 6th May 2018). Previously administered products included TWINRIX Adult (no reaction after 1st dose). Concurrent medical conditions included latex allergy. On 13th December 2016, the patient received the 2nd dose of TWINRIX Adult (intramuscular) 1 ml. On 13th December 2016, an unknown time after receiving TWINRIX Adult, the patient experienced documented hypersensitivity to administered product. In December 2016, the patient experienced eye swelling. On an unknown date, the outcome of the eye swelling and documented hypersensitivity to administered product were unknown. The reporter considered the eye swelling to be possibly related to TWINRIX Adult. Additional details were provided as follows: The patient had latex sensitivity. This led to documented hypersensitivity to administered product. The patient experienced minor swelling under left eye after receiving TWINRIX Adult (right deltoid).
Cellulitis of left thigh developed on 8/21/07. There was increased erythema, edema, tenderness and warmth on the left thigh that was worsening 48 hours after vaccination.
Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; Product temperature excursion issue; patients who were administered the vaccine that underwent temperature excursion; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F), PRODUCT TEMPERATURE EXCURSION ISSUE (Product temperature excursion issue) and EXPIRED PRODUCT ADMINISTERED (patients who were administered the vaccine that underwent temperature excursion) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Nov-2021 at 1:57 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 16-Nov-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Product temperature excursion issue) and EXPIRED PRODUCT ADMINISTERED (patients who were administered the vaccine that underwent temperature excursion). On 16-Nov-2021 at 1:57 PM, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). At the time of the report, PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F), PRODUCT TEMPERATURE EXCURSION ISSUE (Product temperature excursion issue) and EXPIRED PRODUCT ADMINISTERED (patients who were administered the vaccine that underwent temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patients were given dose from vial  that was stored in an ultracold freezer which is colder than they should have been. No concomitant medications were provided by the reporter. No treatment medications were provided by the reporter.
presented to ER with COVID-19 test positivity and shortness of breath.steroids and ivermectin at home  nasal cannula,azithromycin and Rocephin, IV steroids, zinc /vitamin-C. D/C ohome on osygen
I had a Tia stroke two years later taken to ER and the doctors see blood clots from my heart going through my head and other places , must use a heart monitor and baby aspirin
One shot years ago, have shingles now; Apparently I should have been updated; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and did not receive the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and not applicable after receiving Shingles vaccine, the patient experienced shingles and incomplete course of vaccination. On an unknown date, the outcome of the shingles was not recovered/not resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 29-Jul-2022 Reporter's comment: This case was reported by a patient via interactive digital media. The patient had one shot years ago and had shingles at the time of reporting. The patient stated that should have been updated and this was the second time. The patient advised that if it was only one shot be sure to check with your Doctor. Additional Supportive Information: Till the time of reporting the patient had not received the second dose of Shingles vaccine, which led to incomplete course of vaccination. Follow up was not possible as no contact details were available.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 78-year-old male patient who received Shingrix for prophylaxis. On 11th October 2018, the patient received the 1st dose of Shingrix. On 11th December 2018, 61 days after receiving Shingrix, the patient experienced diarrhea and fever. On an unknown date, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm, diarrhea and fever were recovered/resolved. It was unknown if the reporter considered the pain in arm to be related to Shingrix. The reporter considered the diarrhea and fever to be unrelated to Shingrix. Additional details were provided as follows: The patient reported that after the injection with Shingrix on 11th October 2018, he did have a sore arm for a day or two. The patient had an appointment to get his second shot of the series on the date of reporting but was not sure if he should post-pone because on 11th December 2018 or 12th December 2018, he had diarrhea and a fever. These events lasted for less than 24 hours and the fever was 99.7 at the highest point. The patient not attributing these events to Shingrix, both symptoms resolved within 24 hours and was feeling fine. The patient did not want to receive any mail or phone calls from GSK and had provided contact details of the physician.
STAPH INFECTION, FEVER, BOIL, SWOLLEN REDNESS AND SORENESS(INNER THIGH, VAGINAL AREA, AND BUTTOCK AREA),
This spontaneous report as received from a physician refers to a 11 year old female patient. On JUL-2017 the patient was vaccinated with GARDASIL 9 for prophylaxis. Other suspect therapies included MENACTRA and diphtheria toxoid, pertussis acellular vaccine (unspecified), tetanus toxoid. On JUL-2017 the patient experienced fall, tooth loss and nasal injury. The outcome of fall, tooth loss and nasal injury is unknown.
Left testicular dull pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 12May2021 (Lot number: EW0182) at the age of 41 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Mild gastritis" (unspecified if ongoing). Concomitant medication(s) included: HYOSCYAMINE; PANTOPRAZOLE. Vaccination history included: Bnt162b2 (prev dose administration date=21Apr2021, prev dose dose number=1,, prev dose vaccine location=Left arm, prev dose lot number=EW0161,), administration date: 21Apr2021, when the patient was 41 years old, for COVID-19 Immunization. The following information was reported: TESTICULAR PAIN (non-serious) with onset 2021, outcome "recovered" (2021), described as "Left testicular dull pain". Therapeutic measures were not taken as a result of testicular pain. Additional information: No other vaccine in four weeks. No COVID prior vaccination. No COVID tested post vaccination. No follow-up attempts are possible. No further information is expected.
I had a headache, running nose, sneezing, and water eyes for 3 days. Then a week later, my allergies started acting up. I went to see my doctor. He put me on antibodies and steroids'. Then I got a rash on my month. The rash never went away. The roof of my mouth is painful. The referred me to ENT. They did a CT scan and said that I have a tumor in side my nose. On Tuesday, he sent me to get a MRI done to make sure it was not cancer.
Canker sore under tongus; This is a spontaneous report from a contactable consumer (patient).   A patient of unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), via intramuscular, administered in Arm Right on 09Jun2021 10:00 (Batch/Lot Number: EW0217) as dose 2, single for covid-19 immunization at school/student health clinic. Medical history included ongoing multiple sclerosis from 2015, high blood pressure, spasms, tinnitus, cholesterol, sleep, bone disorder, nausea and stroke from 2020 to Sep2020. Concomitant medications included melatonin taken for sleep disorder from 2014 and ongoing; vitamin d3 taken for bone disorder, spasms from 2016 and ongoing; promethazine taken for nausea from 2016 and ongoing; zolpidem taken for sleep disorder from 2016 and ongoing; calcium carbonate, lycopodium clavatum, potassium carbonate, quinine sulfate, salicylic acid (TINNITUS RELIEF) taken for tinnitus from 2017 and ongoing; cyclobenzaprine taken for muscle spasms from 2018 and ongoing; atorvastatin taken for cardiovascular disorder, cholesterol from 2020 and ongoing; propranolol taken for cardiovascular disorder, hypertension from 2020 and on-going; acetylsalicylic acid (ASPIRIN (E.C.) taken for cerebrovascular accident from 2020 and ongoing. Historical vaccine included received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW018B), via an intramuscular route, administered in Arm Right on 17May2021 10:00, as dose 1, single for covid-19 immunization. Prior vaccination (within four weeks) was none. The patient reported that few Days after second dose on 12Jun2021, developed a very large canker sore under my tongue. Which the patient still had. The patient never had one before. And the dentist stated it was very large. The event resulted in physician office. The patient did not receive treatment receive. Relevant tests were none. The event was reported as non-serious. The outcome of event was reported as resolving.   Lot/batch number was not available despite the follow-up attempts made. Follow-up attempts were been completed and no further information was expected.
Pfizer on 2/17 and 3/10. Positive on 9/22
Patient came into pharmacy on 2/17/22 stating he wanted to report issues from his first Pfizer covid 19 dose on 11/23/21. Patient originally called to report but they directed him to come to pharmacy store level and they asked patient to get a claim number which he did not have. Patient stated 3 days after receiving 1st Pfizer dose he had burning/stinging pain, deep soreness, pulsating pain, and muscle spasms. Patient stated no issues with 2nd dose of Pfizer which he had administered in right arm.Patient followed up with physician who told him nerve was struck possibly during vaccine administration causing nerve pain. Patient was prescribed muscle relaxers and physical therapy by physician which patient states is still ongoing as of 2/17/22. Patient states left arm where area of vaccination occurred starting to heal with range of motion getting better with physical therapy but they are continuing to work on building strength back in his left arm. Patient stated left arm is his dominant arm and he had no issues with mobility or pain in his left arm prior to getting the vaccine. Patient wanted to report to us but did not state any legal action or requesting compensation or treatment compensation. Patient was thankful he received 2 doses of Covid vaccine prevented him from getting covid during December and at work when it was going around. Patient inquired when he was eligible for a booster vaccine which HCP wrote down date in 5 months from 2nd dose of Pfizer on her business card and gave to patient. Also offered to mail patient gift card for customer loyalty for using our pharmacy for vaccines for customer service.
Soreness at injection site day 2 that resolved. Diarrhea days 5- present. Hives surrounding injection site started day 9 post injection.
This spontaneous case was reported by a consumer and describes the occurrence of TASTE DISORDER (bad taste in mouth), PYREXIA (Sporadic Low grade fever), FATIGUE (tired) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 Janssen vaccine and Dose 2 Moderna) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for Prophylactic vaccination. Previously administered products included for Prophylactic vaccination: Janssen COVID-19 Vaccine (Dose number 1, batch number 1802072 and left arm with expiry date 31Dec2021. Patient experienced 102 degree fever and outcome was unknown) on 06-Mar-2021. Past adverse reactions to the above products included Fever with Janssen COVID-19 Vaccine. Concurrent medical conditions included Heart block bundle branch (not on pacemaker). On 23-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Oct-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 Janssen vaccine and Dose 2 Moderna). On 24-Oct-2021, the patient experienced TASTE DISORDER (bad taste in mouth). On an unknown date, the patient experienced PYREXIA (Sporadic Low grade fever) and FATIGUE (tired). At the time of the report, TASTE DISORDER (bad taste in mouth), PYREXIA (Sporadic Low grade fever) and FATIGUE (tired) had not resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 Janssen vaccine and Dose 2 Moderna) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Mar-2021, Body temperature: 102 (High) 102 degree Fahrenheit. On an unknown date, Polymerase chain reaction: negative (Negative) Negative. No concomitant medications were reported. The patient was unsure if the patient had enough immunity because they said if patient got 2 doses of vaccine, so will get immunity. Patent asked doctor for another dose, but doctor did not responded. Patent called the health department and then the man said patient would be eligible for another dose until 23Jan2022. The patient lay on couch for a minute and after 3min get back up from couch. It was reported that patient would be visiting cardiology in March. No treatment medications were provided.
Rash appeared 2-3 days following FLUZONE (RA) and ZOSTAVAX (LA) vaccine administration.
Woke up at 2:00 am after injection with  headache,  severe body and joint aches, site injection soreness and hardness, and nauseated. Chills occurred around noon day after injection. still feeling severe body and joint aches, headache and injection site soreness and hardness.
Ran high fever for 24 hours Injection site very swollen and red all the way down arm and white swollen spot around injection point. Very dizzy and sick for 2 days.
first dose of the Moderna COVID-19 Vaccine on January; Tachycardia; erythema around the injection site described as a red; Raised area; Itchy area; local site reaction below the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (local site reaction below the injection site), VACCINATION SITE ERYTHEMA (erythema around the injection site described as a red), VACCINATION SITE SWELLING (Raised area), VACCINATION SITE PRURITUS (Itchy area) and PRODUCT DOSE OMISSION ISSUE (first dose of the Moderna COVID-19 Vaccine on January) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Graves' disease, Asthma (Mild Ashtma) and Thyroidectomy. Concurrent medical conditions included Allergy (Allergic to sulfa.), Iodine contrast media allergy and Drug allergy (Sulpha allergy). Concomitant products included VENLAFAXINE HYDROCHLORIDE (EFFEXOR), LEVOTHYROXINE SODIUM (SYNTHROID), NADOLOL and MACROGOL 3350 (MIRALAX) for an unknown indication.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced VACCINATION SITE REACTION (local site reaction below the injection site). On 19-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (erythema around the injection site described as a red), VACCINATION SITE SWELLING (Raised area) and VACCINATION SITE PRURITUS (Itchy area). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (first dose of the Moderna COVID-19 Vaccine on January) and TACHYCARDIA (Tachycardia). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 19-Jan-2021 for Itchy, Redness and Induration, at an unspecified dose and frequency. On 07-Jan-2021, VACCINATION SITE REACTION (local site reaction below the injection site) had resolved. On 20-Jan-2021, VACCINATION SITE ERYTHEMA (erythema around the injection site described as a red), VACCINATION SITE SWELLING (Raised area) and VACCINATION SITE PRURITUS (Itchy area) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (first dose of the Moderna COVID-19 Vaccine on January) and TACHYCARDIA (Tachycardia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Significant Follow-up contained New Events Tachycardia and Moderna Arm.
received smallpox vaccination 1/31/03 and had a major reaction that resulted in a scar on the left deltoid.  He denies any trauma, rash, pruritus at the site since the major reaction resolved.  Approximately ten days ago he developed a dime-sized area of erythema and pruritus at the site of the scar resulting from the smallpox vaccination. Two days later he noticed a vesicle that was eventually 3  4 mm in diameter with several smaller vesicles also present at the site of the smallpox scar.  He kept these vesicles covered with a bandage until they broke open approximately 3  4 days ago and drained a "clear fluid that was greenish".  A scab has not developed.  The area remains pruritic.  He denies fever, chills, cough, night sweats, nausea, vomiting, diarrhea, upset stomach.
pt recvd vax & verbalized nauseated, weak, felt urge to defecate, diaphoretic;radial pulse 48 & erratic;BP not audible or palpable;paramedics called;color ashen;episode cont for approx 20-30mins;BP 108/60;
In May of 1999 pt received second dose of varicella virus vaccine live. Subsequent laboratory evaluation revealed high titer. In August of 1999 the pt developed varicella. The pt sought unspecified medical attention. Additional information has been requested.